Healthbook TIMES Oncology Hematology

Aims & Scope

To provide a peer-reviewed, indexed, open-access publication platform for oncologists and hematologists in Switzerland and abroad.

To provide a scientific platform dedicated to increasing the exposure of both experienced and young academics and healthcare professionals.

To cover practice-oriented and theoretical research topics in high quality.

To facilitate circulation of novel discoveries in oncology and hematology research.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal does not charge a mandatory Article Processing Charge (APC). However, optional open access publication may incur fees based on the publisher’s policies.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Rare Adverse Events of CAR T-Cell Therapy

  Citation: 2

  Authors:

• Advancements in Machine Learning (ML): Transforming the Future of Blood Cancer Detection and Outcome Prediction

  Citation: 2

  Authors:

• Assessment and Treatment of Elderly Patients with Multiple Myeloma

  Citation: 2

  Authors:

• Genomic Testing for Advanced Prostate Cancer: Ready for Prime Time

  Citation: 1

  Authors: Alexander

• Folate Receptor α: A New Target for an Old Enemy?

  Citation: 1

  Authors:

• Current Advances in the Perioperative Treatment of Muscle-Invasive Bladder Cancer

  Citation: 1

  Authors:

• Benefits and Applications of Oncotype DX Breast Recurrence Score Testing among Breast Cancer Patients: Current Recommendations and Controversies.

  Citation: 1

  Authors:

• Comprehensive Review on PARP Inhibitors in Ovarian Cancer: A Breakthrough in Diagnostic and Therapeutic Approaches

  Citation: 1

  Authors:

• Therapy Management of Metastatic Prostate Carcinoma in General Practice

  Citation: 1

  Authors: Alexander

• Response to Osimertinib in a Patient With Non-Small Cell Lung Cancer and Two Uncommon EGFR mutations

  Citation: 1

  Authors: Christoforos, Adrienne, Daniel C.